Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
MedTech
CRO
Merck KGaA rolls out ‘all-in-one’ CHO genetic stability assay
The platform, called Aptegra, reportedly cuts biosafety testing time for clients by two-thirds, speeding up the commercialization process.
Helen Floersh
Apr 18, 2024 4:05pm
Bruker brokers $392M deal for frayed NanoString
Apr 18, 2024 11:24am
23andMine: Anne Wojcicki aims to take genetics company private
Apr 18, 2024 9:16am
FDA hands de novo clearance to Scopio's bone marrow pathology AI
Apr 17, 2024 12:56pm
Abbott medical device gains drive nearly $10B quarterly haul
Apr 17, 2024 11:37am
J&J CEO says M&A strategy to 'continue' after medtech megadeals
Apr 16, 2024 1:42pm